Internship

Winter Jan 2025 Co-op

Global Antigen Design, Virology, Vaccines

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

No H1B Sponsorship

Waltham, MA, USA

Must be able to relocate to Waltham office and work 40 hours/week for the duration of the Co-op.

Category
Bioinformatics
Computational Biology
Genomics
Public Health
Biology Lab & Research
Diagnostics & Laboratory Professionals
Healthcare Administration & Support
Nursing & Allied Health Professionals
Physicians & Surgeons
Veterinary Professionals
Medical, Clinical & Veterinary
Biology & Biotech
Required Skills
PowerPoint/Keynote/Slides
Requirements
  • Currently pursuing a bachelor's degree or higher in Life Sciences or other related field with the expectation that you will complete your current degree by Spring 2027
  • Must be enrolled in school the semester following your co-op with Sanofi.
  • Must be able to relocate to our Waltham office location work 40hrs./week for the duration of the Co-op
  • Must have permanent US work authorization
  • Preferably some R&D experience from lab courses or other experiences in biochemistry, cell culture, aseptic technique, or lab automated systems.
  • Strong knowledge of MS Office including Excel, PowerPoint and Word
  • Good interpersonal skills, communication, and ability to work independently and on a team, under supervision.
  • Able to perform experiments from verbal or written instructions, while learning and applying new concepts and research procedures.
Responsibilities
  • Complete specific laboratory research tasks under supervision and demonstrate high productivity and consistency, with high quality data.
  • Learn about the fields of Biochemistry by reading scientific literature and interacting with supervisor and team.
  • Maintain and update experiment notebooks according to QA requirements.
  • Participate in lab and equipment maintenance, and re-stocking lab supplies.
  • Attend group meetings and presents data.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse product pipeline and a global presence. The company's goal is to enhance health outcomes and improve the quality of life for individuals worldwide.

Company Stage

Grant

Total Funding

$2B

Headquarters

Paris, France

Founded

N/A

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Sanofi's strong financial performance, as evidenced by its raised 2024 outlook, indicates robust growth and stability.
  • The company's strategic investments in innovative biotech firms, such as Ventyx Biosciences, enhance its pipeline and potential for breakthrough therapies.
  • Sanofi's Dupixent receiving a positive recommendation for expanded use in children demonstrates its leadership in addressing unmet medical needs.

What critics are saying

  • The highly competitive pharmaceutical market requires Sanofi to continuously innovate to maintain its market position.
  • Regulatory challenges in different regions could delay product approvals and impact revenue streams.

What makes Sanofi unique

  • Sanofi's extensive R&D efforts and strategic partnerships, such as with Orano Med for radioligand therapies, set it apart in the competitive pharmaceutical landscape.
  • The company's global reach and focus on patient-centric solutions allow it to effectively navigate diverse regulatory environments and deliver innovative treatments worldwide.
  • Sanofi's investment in sustainable initiatives, like SureChill's 'Cooling as a Service' model, highlights its commitment to addressing healthcare challenges in emerging markets.

Help us improve and share your feedback! Did you find this helpful?